Current Opinion in Nephrology and Hypertension

Article	Citations
Population Health Strategies for Health Equity in Chronic Kidney Disease Management: Retraction	41
Dual organ transplantation: Pancreas and Liver in the kidney axis	40
Emerging strategies to reduce kidney function decline and improve cardiovascular outcomes	28
Editorial introductions	27
Maximizing opportunities for kidney transplantation in older adults	24
Does cooled dialysate still have a role in reducing intradialytic stress? Implications of the MyTEMP trial	22
Effect of the allelic background on the phenotype of primary hyperoxaluria type I	20
Interferon gamma in the pathogenesis of hypertension − recent insights	20
Barriers to home dialysis and kidney transplantation for socially disadvantaged individuals	18
Tackling the intersectoral challenges in kidney diseases and transplantation: shared decision and realistic care for advanced diagnostic and therapeutic modalities for kidney diseases and transplantat	18
The coronavirus disease 2019 pandemic: the disruptor that maintenance dialysis never anticipated	18
Evolution in the targets for blood pressure treatment	17
The impact of conflicts on patients with chronic kidney disease	17
Editorial introduction	17
Prediction models for earlier stages of chronic kidney disease	16
Has the time come for age-adapted glomerular filtration rate criteria to define chronic kidney disease: how soon is now?	16
International equity in access to home dialysis	16
Renal denervation for the treatment of hypertension and kidney disease	14
Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD	14
Bringing the end-stage kidney disease life plan home	13
Modern indications for referral for kidney and pancreas transplantation	13
The race coefficient in glomerular filtration rate-estimating equations and its removal	12
Calcium-binding protein 39 in with-no-lysine kinase signaling and the modulation of renal tubular transport	12
Recent advances in peritoneal dialysis catheter placement: the association between method of insertion, operator, and prior abdominal surgery and outcomes	12
Dialysis initiation for patients with decompensated cirrhosis when liver transplant is unlikely	12

Staying home when peritoneal dialysis ends: the integrated home dialysis approach	12
Skeletal parathyroid hormone hyporesponsiveness: a neglected, but clinically relevant reality in chronic kidney disease	12
Editorial: One size does not fit all: moving toward individualized therapy	11
Built environment and chronic kidney disease: current state and future directions	11
Editorial: The evolution of my personal conflict of interest: I am part of an ‘ineligible company’	11
Plant-based diets for kidney disease prevention and treatment	11
Sodium phosphate cotransporter 2a inhibitors: potential therapeutic uses	11
Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression	11
Synergistic susceptibility to environmental lead toxicity in chronic kidney disease	11
A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?	10
Complement detection in kidney biopsies – utility and challenges	10
Understanding renal phosphate handling: unfinished business	10
Bringing medical education “home”: the university health network and St. Michael's hospital home dialysis fellowship	10
Editorial: Advancements in the management of kidney disease and electrolyte derangements	9
Renal effects of cullin 3 mutations causing familial hyperkalemic hypertension	9
Combination therapy with kidney protective therapies: optimizing the benefits?	9
Dietary protein intake and plant-dominant diets to mitigate risk of allograft dysfunction progression in kidney transplant recipients	9
Lipocalin-2: a novel link between the injured kidney and the bone	9
Which patients with CKD will benefit from genomic sequencing? Synthesizing progress to illuminate the future	9
A guide for program development of environmentally sustainable kidney care	9
Editorial introductions	9
The current therapeutic approach for anaemia after kidney transplant	8
Editorial introductions	8
Cancer drugs and acute kidney injury: new therapies and new challenges	8
Recent updates in kidney risk prediction modeling: novel approaches and earlier outcomes	8
Deep learning applications for kidney histology analysis	8
A current update of the development of Chimeric Antigen Receptor T-cell therapy and kidney disease	8
Automation and innovation in home hemodialysis machines	8
Glucagon-like peptide-1 receptor agonists to improve cardiorenal outcomes: data from FLOW and beyond	8
HIV-associated kidney disease: the changing spectrum and treatment priorities	8
Climate change and kidney stones	8
When the earth shakes unexpectedly: impact on nephrology services and patients	8
Editorial: Innovations in multimodal and integrated approaches in kidney care and renal transplantation	7
New and old approaches to nutritional management of acute and chronic glomerulonephritis	7
Editorial introductions	7
Epithelial Na+ channel and the glycocalyx: a sweet and salty relationship for arterial shear stress sensing	7
Impact of intensive blood pressure control on kidney outcomes	7
Evolving thresholds for the diagnosis of acute T cell mediated rejection	7
Editorial introduction	7
C3 glomerulopathy: advancements in diagnostics and therapeutics	7
Mitochondrial bioenergetics: coupling of transport to tubular mitochondrial metabolism	7
Recent advances in treatment options for kidney disease	7
Editorial introductions	7
Prospects for gene therapy in polycystic kidney disease	7
New insights into renal calcium-sensing receptor activation	6
Rare genetic disorders that impair parathyroid hormone synthesis, secretion, or bioactivity provide insights into the diagnostic utility of different parathyroid hormone assays	6
Building kidney organoids from pluripotent stem cells	6
Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges	6
Sex differences in renal electrolyte transport	6
Screening for chronic kidney disease: change of perspective and novel developments	6

Contemporary risk prediction models in chronic kidney disease: when less is more	6
Multimodal approaches for inequality in kidney care: turning social determinants of health into opportunities	6
New therapeutic perspectives for vascular and valvular calcifications in chronic kidney disease	6
Renal osteodystrophy: something old, something new, something needed	6
Renal denervation: recent developments in clinical and preclinical research	6
Prevention of postoperative acute kidney injury: insights from recent clinical trials	6
Vaccination in kidney disease: what did we learn from COVID-19 pandemic	6
Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?	5
Exercise as a therapeutic intervention in chronic kidney disease: are we nearly there yet?	5
Proximal tubule responses to injury: interrogation by single-cell transcriptomics	5
Peritoneal dialysis and heart failure	5
WNK1 in the kidney	5
The potential of artificial intelligence-based applications in kidney pathology	5
Population health strategies for health equity in chronic kidney disease management	5
Evolving indications and management patterns in heart – kidney transplantation	5
An update on corticosteroid treatment for IgA nephropathy	5
Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era	5
Therapies in autosomal dominant polycystic kidney disease: beyond tolvaptan	5
Frailty, multimorbidity and sarcopaenia in haemodialysis patients	5
New guidelines and therapeutic updates for the management of lupus nephritis	5
Role of inwardly rectifying K+ channel 5.1 (Kir5.1) in the regulation of renal membrane transport	5
Novel agents for treating IgA nephropathy	5
Editorial introductions	5
Fibroblast growth factor 23 as a risk factor for incident diabetes	5
The genetics of cystinuria – an update and critical reevaluation	5
Staff-assisted peritoneal dialysis in the United States: from evidence to national adoption	5
Chronic kidney disease and sex dimorphism	5
Novel approaches in antihypertensive pharmacotherapeutics	5
The changing trajectory of diabetic kidney disease	5
Targeting inflammation in hypertension	5
The role of calprotectin in vascular calcification	5
Effects of aging on chronic kidney disease mineral and bone disorder	5
New therapeutics for primary hyperoxaluria type 1	5
Cystatin C should be routinely available for estimating kidney function	5
The role of osteopontin in chronic kidney disease-mineral bone disorder	4
Methotrexate nephrotoxicity: a pragmatic approach	4
Insights into proliferative glomerulonephritis with monoclonal immunoglobulin deposits – is it really monoclonal or not?	4
Electrolytes disturbances in cancer patients	4
Persistent hyperparathyroidism in long-term kidney transplantation: time to consider a less aggressive approach	4
Agents to treat osteoporosis in chronic kidney disease	4
The times they are K+-changin’: bringing the potassium curriculum out of the 20th century	4
Editorial introductions	4
Indications for and results of renal autotransplantation	4
Climate change and its influence in nephron mass	4
Implications of climate change on acute kidney injury	4
Editorial introductions	4
Postnatal renal tubule development: roles of tubular flow and flux	4
Glomerular filtration rate and sexual dimorphism: lessons from animal and human studies	4
The promise of artificial intelligence for kidney pathophysiology	4
Medullary sponge kidney and chronic pain: is there a role for renal denervation	4
Climate crisis and nephrology: a review of climate change's impact on nephrology and how to combat it	4
Novel insights in the regulation of intercalated cell differentiation	4
Centering marginalized voices in advocacy for equitable policy change in kidney disease	4
Updates on renal phosphate transport	4
Phosphate sensing in health and disease	4
Updated diagnostic and therapeutic management for membranous nephropathy	4
Editorial: Narrow the gap, build a bridge: an inspirational approach to chronic kidney disease–mineral and bone disorder	4
Fifty years of basic and clinical renal stone research: have we achieved major breakthroughs? A debate	4
Mendelian randomization and the association of fibroblast growth factor-23 with heart failure with preserved ejection fraction	4
Diagnosing acute tubulointerstitial nephritis: novel biomarkers address an important clinical challenge	4
Progress in the management of patients with diabetes and chronic kidney disease	4
Use of water in dialysis and its impact on the environment	4
Editorial introductions	4
Mitochondrial DNA – novel mechanisms of kidney damage and potential biomarker	4
Pruritus in chronic kidney disease	4
Literature review: are NSAIDs harmful and is acetaminophen well tolerated?	4
Home dialysis: there's no place like home	4
Justifying access to kidney care in low resource and humanitarian settings	3
Editorial introductions	3
Artificial intelligence in kidney disease and dialysis: from data mining to clinical impact	3
Management of antineutrophil cytoplasmic antibody-associated vasculitis: a changing tide	3
Social and humanitarian issues in nephrology and hypertension	3
Let's stop talking about ‘citrate toxicity’	3
Applications of cardiac biomarkers in chronic kidney disease	3
Biopsy-based transcriptomics in the diagnosis of kidney transplant rejection	3
Editorial introductions	3
Skin autofluorescence as tool for cardiovascular and diabetes risk prediction	3
Community acquired and hospital acquired AKI - two diseases divided by a common definition	3
Fibroblast growth factor 23, klotho and heparin	3
The obesity and lipid paradoxes in chronic kidney disease: mechanisms, interventions, and future directions	3

Update on antineutrophil cytoplasmic antibody vasculitis	3
Heating up: climate change and the threat to human health	3
Recent advances in the understanding of the peritoneal membrane	3
Lysine and salt-sensitive hypertension	3
APOL1-associated kidney disease: modulators of the genotype-phenotype relationship	3
Challenges in standardizing preimplantation kidney biopsy assessments and the potential of AI-Driven solutions	3
Novel pharmacological interventions for diabetic kidney disease	3
Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation	3
Role of artificial intelligence in the diagnosis and management of kidney disease: applications to chronic kidney disease and acute kidney injury	3
Kidney health and function with left ventricular assist devices	3
Oh, My Gut! New insights on the role of the gastrointestinal tract and the gut microbiome in chronic kidney disease-mineral and bone disorder	3
Challenges and advances in the management of antineutrophil cytoplasmic antibody vasculitis in 2025	3
Do not forget about transplant patients during disasters	3
Revisiting the relationship between (Pro)Renin receptor and the intrarenal RAS: focus on the soluble receptor	3
Targeting aldosterone to improve cardiorenal outcomes: from nonsteroidal mineralocorticoid receptor antagonists to aldosterone synthase inhibitors	3
Vasopressin, protein metabolism, and water conservation	2
Enabling flourishing: novel approaches in palliative medicine for children with advanced kidney disease	2
Harm! foul! How acute kidney injury SHReDDs patient futures	2
APOL1 nephropathy – a population genetics success story	2
The cardiovascular unphysiology of thrice weekly hemodialysis	2
Contribution of phosphate and FGF23 to CKD progression	2
Immune checkpoint inhibitors and kidney disease	2
The climate impact of dialysis	2
Moving beyond the syndrome: how can acute kidney injury phenotypes help?	2
Hypertension in Pregnancy: What We Now Know	2
Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?	2
Kidney function assessment in the geriatric population	2
Uromodulin: more than a marker for chronic kidney disease progression	2
Chronic kidney disease with unknown cause across the global spectrum	2
SLC26A1 directs sulfate homeostasis in health and disease	2
Treatment potential in APOL1-associated nephropathy	2
Treatment of acute metabolic acidosis	2
Type 4 renal tubular acidosis and uric acid nephrolithiasis: two faces of the same coin?	2
Metabolic dysfunction associated steatotic liver and kidney stones: what is going on?	2
Back to the future: a review of peritoneal dialysis for acute kidney injury	2
Novel indications for referral and care for simultaneous liver kidney transplant recipients	2
Optimizing renin–angiotensin–aldosterone inhibition in advanced chronic kidney disease: balancing benefits and risks	2
The genetic spectrum of Gitelman(-like) syndromes	2
Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease	2
The TMEM16A channel as a potential therapeutic target in vascular disease	2
Quality of life in people with chronic kidney disease: focusing on modifiable risk factors	2
A review of the AURORA and BLISS trials: will it revolutionize the treatment of lupus nephritis?	2
Editorial introductions	2
Prospective collagen IVα345 therapies for Alport syndrome	2